Application | Comment | Organism |
---|---|---|
drug development | AChE is a target for development of improved inhibitots in therapy of Alzheimer's disease | Homo sapiens |
medicine | inhibition of acetylcholinesterase and therefore prevention of acetylcholine degradation is one of the most accepted therapy opportunities for Alzheimer's disease | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
10-hydroxy-infractopicrin | isolated from Cortinarius infractus, inhibits acetylcholinesterase, but does not inhibit butyrylcholinesterase | Homo sapiens | |
galanthamine | inhibits also butyrylcholinesterase | Homo sapiens | |
infractopicrin | isolated from Cortinarius infractus, inhibits acetylcholinesterase, but does not inhibit butyrylcholinesterase | Homo sapiens | |
additional information | inhibitors docking studies, enzyme binding structure and molecular modeling, overview | Homo sapiens | |
physostigmine | inhibits also butyrylcholinesterase | Homo sapiens | |
tacrine | inhibits also butyrylcholinesterase | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | bioassay for inhibition of fibril formation, i.e. Thioflavin T assay | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
AChE | - |
Homo sapiens |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00071 | - |
- |
Homo sapiens | tacrine | |
0.0026 | - |
- |
Homo sapiens | physostigmine | |
0.0087 | - |
- |
Homo sapiens | galanthamine | |
0.0097 | - |
- |
Homo sapiens | infractopicrin | |
0.0127 | - |
- |
Homo sapiens | 10-hydroxy-infractopicrin |